252 related articles for article (PubMed ID: 19428074)
1. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.
Barak M; Mecz Y; Lurie A; Gruener N
J Lab Clin Med; 1989 May; 113(5):598-603. PubMed ID: 2469756
[TBL] [Abstract][Full Text] [Related]
3. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
Ann Urol (Paris); 1989; 23(6):528-30. PubMed ID: 2482700
[TBL] [Abstract][Full Text] [Related]
4. [Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients].
Rodríguez Duarte C
Arch Esp Urol; 1991; 44(6):697-700. PubMed ID: 1722962
[TBL] [Abstract][Full Text] [Related]
5. Transurethral resection in prostatic cancer.
Fujita K; Kimura T; Saito K; Sangen H; Furuhata T; Uyama K; Ogura K; Ueno F
Clin Ther; 1988; 10 Spec No():12-5. PubMed ID: 2466566
[TBL] [Abstract][Full Text] [Related]
6. [Transurethral resection of the prostatic gland (TUR-P) and incidental carcinoma].
Asakawa M; Yasumoto R; Kamizuru M; Maekawa M
Hinyokika Kiyo; 1988 Jun; 34(6):1003-5. PubMed ID: 2464913
[TBL] [Abstract][Full Text] [Related]
7. The effects of transurethral prostatectomy on serum prostate specific antigen.
Vesey SG; Goble NM; Stower MJ; Hammonds JC; Smith PJ
Br J Urol; 1988 Oct; 62(4):347-51. PubMed ID: 2461243
[TBL] [Abstract][Full Text] [Related]
8. Indications for prostatectomy in the treatment of benign hyperplasia of the prostate.
Liu YT; Wan HL; Zhao JH
Scand J Urol Nephrol Suppl; 1991; 138():63-5. PubMed ID: 1723813
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies of transurethral resection in patients with benign prostatic hypertrophy].
Nakajima H; Mori K; Ohnishi S; Kato S; Tanda H
Hinyokika Kiyo; 1988 Aug; 34(8):1411-4. PubMed ID: 2461645
[TBL] [Abstract][Full Text] [Related]
10. [Effects of transurethral resection on the serum concentration of prostate specific antigen and prostatic acid phosphatase].
Morote J; de Torres JA
Actas Urol Esp; 1990; 14(5):356-7. PubMed ID: 1705076
[TBL] [Abstract][Full Text] [Related]
11. [Incidental carcinoma of the prostate].
Vecchioli Scaldazza C; Garritano A; Rossi G; Albini C
Arch Ital Urol Nefrol Androl; 1989 Mar; 61(1):37-42. PubMed ID: 2469128
[TBL] [Abstract][Full Text] [Related]
12. Influence of prostatic disease and prostatic manipulations on the concentration of prostate-specific antigen.
Walz PH; Schoppmann T; Büscher C; Ennen J; Schriewer H
Eur Urol; 1992; 22(1):20-6. PubMed ID: 1385141
[TBL] [Abstract][Full Text] [Related]
13. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.
Roos NP; Wennberg JE; Malenka DJ; Fisher ES; McPherson K; Andersen TF; Cohen MM; Ramsey E
N Engl J Med; 1989 Apr; 320(17):1120-4. PubMed ID: 2469015
[TBL] [Abstract][Full Text] [Related]
14. Quantification of prostatic cancer metastatic disease using prostate-specific antigen.
Vesey SG; Goble M; Ferro MA; Stower MJ; Hammonds JC; Smith PJ
Urology; 1990 Jun; 35(6):483-6. PubMed ID: 1693796
[TBL] [Abstract][Full Text] [Related]
15. [Open surgery of elderly patients with benign prostatic hypertrophy].
Kurokawa K; Tamura Y; Ogura H; Kurihara J; Kobayashi M; Jinbo S; Suzuki T; Imai K; Yamanaka H
Hinyokika Kiyo; 1990 Oct; 36(10):1167-72. PubMed ID: 1702261
[TBL] [Abstract][Full Text] [Related]
16. [Incidental prostatic carcinoma obtained from the tissue by transurethral resection].
Masuda M; Ishibashi Y; Fukuoka H; Sakanishi S
Hinyokika Kiyo; 1989 Mar; 35(3):403-7. PubMed ID: 2472051
[TBL] [Abstract][Full Text] [Related]
17. Prostatic cancer as an incidental finding on prostatectomy.
Rummelhardt S
Prog Clin Biol Res; 1976; 6():95-101. PubMed ID: 66700
[No Abstract] [Full Text] [Related]
18. Alterations in sphingomyelin and fatty acids in human benign prostatic hyperplasia and prostatic cancer.
Narayan P; Dahiya R
Biomed Biochim Acta; 1991; 50(9):1099-108. PubMed ID: 1724598
[TBL] [Abstract][Full Text] [Related]
19. The association of benign prostatic hyperplasia and cancer of the prostate.
Bostwick DG; Cooner WH; Denis L; Jones GW; Scardino PT; Murphy GP
Cancer; 1992 Jul; 70(1 Suppl):291-301. PubMed ID: 1376199
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic and biological correlations (PSA-PAP) in pathology of the prostate. Apropos of 150 cases].
Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
J Urol (Paris); 1990; 96(4):199-201. PubMed ID: 1698882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
